MedPath

Sennosides

Generic Name
Sennosides
Brand Names
Colace, EX-lax Chocolated, EX-lax Maximum Relief Formula, EX-lax Regular Strength Pills, Laxacin, Little Tummys Laxative Drops, Perdiem Overnight, Peri-colace Reformulated Feb 2008, Senexon, Senexon S, Senna Lax, Senna-time, Senokot, Senokot-S
Drug Type
Small Molecule
Chemical Formula
C42H38O20
CAS Number
517-43-1
Unique Ingredient Identifier
3FYP5M0IJX

Overview

Sennosides (also known as senna glycoside or senna) is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl or castor oil. Sennoside A, one of the sennosides present in the laxative medication, has recently proven effective in inhibiting the ribonuclease H (RNase H) activity of human immunodeficiency virus (HIV) reverse transcriptase .

Background

Sennosides (also known as senna glycoside or senna) is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl or castor oil. Sennoside A, one of the sennosides present in the laxative medication, has recently proven effective in inhibiting the ribonuclease H (RNase H) activity of human immunodeficiency virus (HIV) reverse transcriptase .

Indication

For the over the counter treatment of constipation.

Associated Conditions

  • Autointoxication
  • Constipation
  • Haemorrhoids
  • Meteorism

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Geri-Care Pharmaceutical Corp
57896-458
ORAL
8.6 mg in 1 1
3/24/2025
Bryant Ranch Prepack
71335-1181
ORAL
8.6 mg in 1 1
4/29/2025
PAI Holdings, LLC dba PAI Pharma
0121-4967
ORAL
8.8 mg in 5 mL
4/28/2025
Atlantis Consumer Healthcare, Inc.
67618-110
ORAL
8.6 mg in 1 1
4/17/2025
ATLANTIC BIOLOGICALS CORP.
17856-1127
ORAL
417.12 mg in 237 mL
5/23/2025
Walgreens
0363-8750
ORAL
8.6 mg in 1 1
5/7/2025
Meijer, Inc.
79481-0555
ORAL
8.6 mg in 1 1
3/24/2025
Cardinal Health
70000-0519
ORAL
8.6 mg in 1 1
3/26/2025
Safecor Health, LLC
48433-222
ORAL
8.8 mg in 5 mL
6/7/2025
Geri-Care Pharmaceutical Corp
57896-454
ORAL
8.6 mg in 1 1
5/15/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
SENNA TABLET 7.5 mg
SIN02550P
TABLET
7.5 mg
4/19/1989
SENOKOT TABLET 7.5 mg
SIN04731P
TABLET
7.5 mg
6/25/1990

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
EASUWEI SENNOSIDES TABLETS 20MG
N/A
N/A
N/A
11/4/2024
SENCOLAX TAB 7.5MG
N/A
hysan pharmaceutical co ltd
N/A
N/A
7/9/2010
NEPURGO SENNOSIDES TABLETS 20MG
N/A
N/A
N/A
11/4/2024
EFORMAT SENNOSIDES TABLETS 20MG
N/A
N/A
N/A
11/4/2024
© Copyright 2025. All Rights Reserved by MedPath